| Description |
xi, 415 pages : illustrations ; 26 cm |
| Series |
Advances in experimental medicine and biology ; v. 498 |
|
Advances in experimental medicine and biology ; v. 498
|
| Contents |
Machine derived contents note: Epidemiology and Genetic Determinants of Diabetes Mellitus. Type 2 Diabetes In Youth: A New Epidemic; H. Dean. Undiagnosed Diabetes; Burden and Significance in the Canadian Population; T.K. Young. Genes, Environment and Diabetes in Canadian Aboriginal Communities; R.A. Hegele. Diabetes in Sub-Saharan Africa; T.J. Aspray, N. Unwin. Coronary Heart Disease and Risk Factors in Asian Indians; M. Chandalia, P.C. Deedwania. Metabolic Risk Factors in Diabetes and Cardiovascular Disease. The Plasma Glucose Level - A Continuous Risk Factor for Vascular Disease in Both Diabetic and Non-Diabetic People; H.C. Gerstein. Modified Lipoproteins and Cardiovascular Risk; W. Aldahi, J. Frohlich. Advances in Lipid-Lowering Therapy in Atherosclerosis; J. Davignon. Homocysteine as a Risk Factor in Cardiovascular Disease; D.E.C. Cole. Endothelial Function and Diabetes. Endothelial Integrity and Repair; T.J. Lee , et al. Molecular Mechanisms of Endothelial Dysfunction in the Diabetic Heart; P.Rs̲en, et al. A Study of Vascular Wound Healing in a Rabbit Model of Type I Diabetes; N.K. Schiller, et al. Endothelins in the Microvasculature and Heart in Diabetes; S,Chakrabarti, et al. Diabetes and Endothelial Function: Implications for Coronary Angioplasty; T.J. Anderson. Hypertension and diabetes mellitus. The Effect of Hypertension in Diabetes; E.D. Burgess. The Diabetic Hypertensive (or Hypertensive Diabetic) - A Compelling Need to Optimize Blood Pressure; S.G. Carruthers. Left Ventricular Diastolic Dysfunction in Diabetic or Hypertensive Subjects: Role of Collagen Alterations; T.J. Regan, et al. Alterations in the Vascular Actions of Insulin in the Pathogenesis of Insulin Resistance and Hypertension; S. Verma, J.H. McNeill. Cardiac Hypertrophy in Diabetes Patients with and without Hypertension: Effects of Troglitazone, A Novel Antidiabetic Drug, on Diastolic Function; N. Makino, et al. Cost and Benefits of Blood Pressure Monitoring and Control; A. Chockalingam, N.R.C. Campbell. Cardiac lipid metabolism in diabetes. Malonyl COA Control of Fatty Acid Oxidation in the Diabetic Rat Heart; G.D. Lopaschuk. Alterations in 1,2-Diacylglycerols and Ceramides in Diabetic Rat Heart; K. Okumura, et al. Regulations of Myocardial Phospholipid N-Methylation by Insulin and Diabetes; S.W. Schaffer, M. Mozaffari. Reduction Of Phosphatidylinositol-4,5-Bisphosphate Mass In Heart Sarcolemma During Diabetic Cardiomyopathy; P.S. Tappia, et al. Tumor Necrosis Factor-&agr;, Sphingomyelinase and Ceramides Activate Tyrosine Kinase, P21ras and Phosphatidylinositol 3-Kinase: Implications for Glucose Transport and Insulin Resistance; A.N. Hanna, et al. Cardiac Function and Oxidative Stress in Diabetes. Antioxidants, Free Radical Stress and Diabetes; S.S. Rastogi, R.B. Singh. Oxidative Stress and Functional Deficit in Diabetic Cardiomyopathy; P.K. Singal. Ketosis and the Generation of Oxygen Radicals in Diabetes Mellitus; S.K. Jain, K. Kannan. Effect of Diabetes Mellitus on Hemodynamic and Cardiometabolic Correlates in Experimental Myocardial Infarction; S.K. Gupta, et al. Cardiac Function in Perfused Hearts From Diabetic Mice; D.D. Belke. Mg2+-Dependent Atpase Activity In Cardiac Myofibrils From The Insulin Resistant Jcr: La-Cp Rat; T. Misra. Cyclic Nucleotide Phosphodiesterase Families in Intracellular Signalling And Diabetes; C. Lugnier. Alterations in G-Protein-Linked Signal Transduction in Cardiovascular Smooth Muscle in Diabetes; M.B. Anand-Srivastava. Glycemic Control and Improved Cardiovascular Function. Mechanism of HDL Lowering in Insulin Resistant States; G.P. Lewis et al. Insulin Treatment Post Myocardial Infarction: The Digami Study; K. Malmberg, et al. Response to Ischemia and Endogenous Myocardial Protection in the Diabetic Heart; T. Ravingerova, et al. Type 2 Diabetes: Pharmacological Intervention in an Animal Model; J.C. Russell. The Diabetic Heart and Cardiac Glycosides; M. Nagano. Hyperglycemia-Induced Protein Kinase Signaling Pathways in Vascular Smooth Muscle Cells: Implications in the Pathogenesis of Vascular Dysfunction in Diabetes; A.K. Srivastava. Regulation of Myocardial and Skeletal Muscle NA, K-ATPase in Diabetes Mellitus in Humans and Animals; H. Bundgaard, K. Kjeldsen. Diabetes Management a Multidisciplinary Approach. Food Strategies for Diabetes and Heart Health; K. Camelon. The Atherosclerosis Reversal Clinic: The Way of the Future; K.J. Kingsbury, J. Frohlich. Lipid Clinics/Cardiovascular Risk Reduction Clinics Current State and Future Consideration; J. Frohlich, K. Kingsbury. Amputation Prevention and Rehabilitation in Diabetes; J.M. Embil. Laboratory Testing In Diabetes Mellitus; M. Leroux. Health Promotion in Preventing Diabetes and its Complications. Diabetes and Cardiovascular Disease; B. O'Connor. Prevalence of Cardiovascular Risk Factors in Canadians with Diabetes Mellitus; D.R. MacLean, et al. G7 Project Promoting Heart Health; J.L. O'Loughlin, et al. Canadian Heart Health Initiative: Research Review; D. Harvey. Health Policy and National Strategies in Diabetes. Putting Policy into Action; S.M. MacDonald. National and International Strategies to Prevent Obesity and Diabetes; B.A. Reeder. The Diabetes Council of Canada (DCC): Coordinating National Diabetes Strategies; N.W. Rodger. The Federal Government and Diabetes an Incremental Process; W.P. Mickelson |
| Bibliography |
Includes bibliographical references and index |
| Subject |
Diabetic angiopathies.
|
|
Diabetes Complications.
|
|
Cardiovascular Diseases -- etiology.
|
| Genre/Form |
Congress.
|
|
Conference papers and proceedings.
|
| Author |
Angel, Aubie.
|
| LC no. |
2001041362 |
| ISBN |
0306466376 : |
|
